Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  American Journal of Human Genetics

• Publication date

  1996-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8644746PMCID PMC1914678
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The lipoprotein lipase (Asn291-->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia.

  1996cited by this paper
• The lipoprotein lipase (ASN291→SER) mutation is associated with elevated lipid levels in familial combined hyperlipidemia

  1995cited by this paper
• Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability.

  1995cited by this paper
• LDL physical and chemical properties in familial combined hyperlipidemia.

  1995cited by this paper
• Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 British families with familial combined hyperlipidemia.

  1994cited by this paper
• Genetics of low-density lipoprotein subclasses

  1993cited by this paper
• Impaired chylomicron remnant clearance in familial combined hyperlipidemia.

  1993cited by this paper
• Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia.

  1993cited by this paper
• Inheritance of plasma apolipoprotein B levels in families of patients undergoing coronary arteriography at an early age

  1993cited by this paper
• Genotype at a major locus with large effects on apolipoprotein B levels predicts familial combined hyperlipidemia

  1993cited by this paper
• Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B.

  1993cited by this paper
• Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia.

  1993cited by this paper
• Differences in the low density lipoprotein subfraction profile between oral contraceptive users and controls.

  1993cited by this paper
• Complex segregation analysis of LDL peak particle diameter

  1993cited by this paper
• Both inherited susceptibility and environmental exposure determine the low-density lipoprotein-subfraction pattern distribution in healthy Dutch families.

  1992cited by this paper
• Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19.

  1992cited by this paper
• Familial combined hyperlipidemia and abnormal lipoprotein lipase.

  1992cited by this paper
• Change in LDL particle size is associated with change in plasma triglyceride concentration.

  1992cited by this paper
• LDL particle size distribution. Results from the Framingham Offspring Study.

  1992cited by this paper
• Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.

  1991cited by this paper
• Familial combined hyperlipidaemia linked to the apolipoprotein AI–CIII–AIV gene cluster on chromosome 11q23q–q24

  1991cited by this paper
• Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia.

  1990cited by this paper
• Equivalence of the mixed and regressive models for genetic analysis. I. Continuous traits

  1989cited by this paper
• Familial combined hyperlipidemia workshop

  1989cited by this paper
• Low density lipoprotein subfractions and relationship to other risk factors for coronary artery disease in healthy individuals.

  1989cited by this paper
• Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis.

  1988cited by this paper
• Some metabolic characteristics of low-density lipoprotein subfractions, LDL-1 and LDL-2: in vitro and in vivo studies.

  1988cited by this paper
• Plasma Lipoproteins, Apolipoproteins, and Triglyceride Metabolism in Familial Hypertriglyceridemia

  1986cited by this paper
• Genetic control of low-density-lipoprotein subclasses.

  1986cited by this paper
• Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.

  1983cited by this paper
• Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia.

  1981cited by this paper
• A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein.

  1980cited by this paper
• Immunonephelometric assay of human apolipoprotein AI.

  1980cited by this paper
• A genetic determinant of the phenotypic variance of the molecular weight of low density lipoprotein.

  1975cited by this paper
• A new look at the statistical model identification

  1974cited by this paper
• Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia.

  1973cited by this paper

• Interaction Between Primary Hyperlipidemias and Type 2 Diabetes: Therapeutic Implications

  2024cites this paper
• Effects of phytosterol supplementation on lipoprotein subfractions and LDL particle quality

  2024cites this paper
• Pediatric dyslipidemias: lipoprotein metabolism disorders in children

  2021cites this paper
• Familial Hypercholesterolemia: Three “under” (Understood, Underdiagnosed, and Undertreated) Disease

  2021cites this paper
• METABOLIC AND GENETIC ASPECTS OF FCH 803

  2017cites this paper
• 5-Year Follow-Up Study Nomogram to Diagnose Familial Combined Hyperlipidemia on the Basis of Results of a

  2017cites this paper
• "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses.

  2011cites this paper
• Linkage and association analyses identify a candidate region for apoB level on chromosome 4q32.3 in FCHL families

  2010cites this paper
• Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway.

  2010cites this paper
• Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus

  2010cites this paper
• Paraoxonase (PON1) is associated with familial combined hyperlipidemia.

  2008cites this paper
• Diagnosing familial hypercholesterolaemia: the relevance of genetic testing.

  2006cites this paper
• Nutrition, body weight and deterioration of familial combined hyperlipidemia.

  2006cites this paper
• LDL particle size, fat distribution and insulin resistance in obese children

  2006cites this paper
• The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia

  2006cites this paper
• Impaired endothelium-dependent vascular reactivity in patients with familial combined hyperlipidaemia

  2006cites this paper
• Detection of a major gene effect for LDL peak particle diameter and association with apolipoprotein H gene haplotype.

  2005cites this paper
• Characterisation of the lipoprotein structure in the St. Thomas' Mixed Hyperlipidaemic (SMHL) rabbit.

  2005cites this paper
• Decreased adiponectin levels in familial combined hyperlipidemia patients contribute to the atherogenic lipid profile Published, JLR Papers in Press, August 16, 2005. DOI 10.1194/jlr.M500212-JLR200

  2005cites this paper
• Effects of Atorvastatin and Simvastatin on Low-Density Lipoprotein Subtraction Profile, Low-Density Lipoprotein Oxidizability, and Antibodies to Oxidized Low-Density Lipoprotein in Relation to Carotid Intima Media Thickness in Familial Hypercholesterolemia

  2004cites this paper
• Association of apolipoprotein A5 variants with LDL particle size and triglyceride in Japanese Americans.

  2004cites this paper
• Detection of early atherosclerosis using the ultrasound parameter of the intima-media thickness of the common carotid artery in families with familial combined hyperlipidemia.

  2004cites this paper
• Diagnostic Criteria in Relation to the Pathogenesis of Familial Combined Hyperlipidemia

  2004cites this paper
• Genetics of LDL particle heterogeneity: from genetic epidemiology to DNA-based variations.

  2004influential citation
• Nomogram to Diagnose Familial Combined Hyperlipidemia on the Basis of Results of a 5-Year Follow-Up Study

  2004cites this paper
• Thioredoxin interacting protein in Dutch families with familial combined hyperlipidemia

  2004cites this paper
• GENETIC SUSCEPTIBILITY TO THE METABOLIC SYNDROME

  2004cites this paper
• Genomewide Scan for Quantitative Trait Loci Influencing Low-density Lipoprotein Size and Plasma Triglyceride in Familial Hypertriglyceridemia

  2003cites this paper
• Determinants of low HDL levels in familial combined hyperlipidemia Published, JLR Papers in Press, June 1, 2003. DOI 10.1194/jlr.M300069-JLR200

  2003cites this paper
• Evidence for a Major Quantitative Trait Locus on Chromosome 17q21 Affecting Low-Density Lipoprotein Peak Particle Diameter

  2003cites this paper
• Heritability of LDL peak particle diameter in the Quebec Family Study

  2003cites this paper
• Genome-wide scan for quantitative trait loci influencing LDL size and plasma triglyceride in familial hypertriglyceridemia Published, JLR Papers in Press, August 16, 2003. DOI 10.1194/jlr.M300272-JLR200

  2003cites this paper
• LDL oxidation and LDL particle size in the development of atherosclerosis

  2002influential citation
• Susceptibility of LDL to oxidation in vitro and antioxidant capacity in familial combined hyperlipidemia: comparison of patients with different lipid phenotypes

  2002cites this paper
• Increased Intima-Media Thickness in Familial Combined Hyperlipidemia Associated With Apolipoprotein B

  2002cites this paper
• LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins.

  2002cites this paper
• Diagnosis of Familial Combined Hyperlipidemia Based on Lipid Phenotype Expression in 32 Families: Results of a 5-Year Follow-Up Study

  2002cites this paper
• Identification of the PPARA locus on chromosome 22q13.3 as a modifier gene in familial combined hyperlipidemia.

  2002cites this paper
• Genetic influences contributing to LDL particle size in familial combined hyperlipidaemia

  2002cites this paper
• Excess coronary heart disease in Familial Combined Hyperlipidemia, in relation to genetic factors and central obesity.

  2001cites this paper
• Effects of Peritoneal Dialysis with an Overnight Icodextrin Dwell on Parameters of Glucose and LIPID Metabolism

  2001cites this paper
• Two newly identified SNPs in the APO AI‐CIII intergenic region are strongly associated with familial combined hyperlipidaemia

  2001cites this paper
• A major gene effect on fasting insulin and insulin sensitivity in familial combined hyperlipidemia.

  2001influential citation
• Pathophysiology of adipose tissue metabolism and atherosclerosis in familial combined hyperlipidemia

  2001cites this paper
• Capillary isotachophoretic analysis of serum lipoproteins using a carrier ampholyte as spacer ion

  2000cites this paper
• Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: a study in familial combined hyperlipidemia.

  2000cites this paper
• Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype

  2000cites this paper
• Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia.

  2000cites this paper
• The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia.

  2000cites this paper
• Reduced hormone-sensitive lipase activity is not a major metabolic defect in Finnish FCHL families.

  2000cites this paper
• The V73M mutation in the hepatic lipase gene is associated with elevated cholesterol levels in four Dutch pedigrees with familial combined hyperlipidemia.

  2000cites this paper
• The V 73 M mutation in the hepatic lipase gene is associated with elevated cholesterol levels in four Dutch pedigrees with familial combined hyperlipidemia

  2000cites this paper
• Impaired free fatty acid suppression during hyperinsulinemia is a characteristic finding in familial combined hyperlipidemia, but insulin resistance is observed only in hypertriglyceridemic patients.

  2000cites this paper
• Insulin resistance in the St. Thomas' mixed hyperlipidaemic (SMHL) rabbit, a model for familial combined hyperlipidaemia.

  2000cites this paper
• A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11.

  1999cites this paper
• Novel genes for familial combined hyperlipidemia.

  1999cites this paper
• Pleiotropic genetic effects on LDL size, plasma triglyceride, and HDL cholesterol in families.

  1999cites this paper
• Linkage analysis of candidate genes and the small, dense low-density lipoprotein phenotype.

  1999cites this paper
• A genome search identifies major quantitative trait loci on human chromosomes 3 and 4 that influence cholesterol concentrations in small LDL particles.

  1999cites this paper
• Genetics of familial combined hyperlipidemia

  1999cites this paper
• Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency.

  1999cites this paper
• Lipoprotein (a) concentrations in patients with familial combined hyperlipidemia and hypertension.

  1999cites this paper
• Inheritance of LDL peak particle diameter: Results from a segregation analysis in Israeli families

  1999cites this paper
• Linkage of a candidate gene locus to familial combined hyperlipidemia: lecithin:cholesterol acyltransferase on 16q.

  1999cites this paper
• Defects of lipoprotein metabolism in familial combined hyperlipidaemia.

  1998cites this paper
• Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins.

  1998cites this paper
• Haplotypes of the ApoA-I/C-III/A-IV gene cluster and familial combined hyperlipidemia.

  1998cites this paper
• Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype.

  1998cites this paper
• The atherogenic significance of an elevated plasma triglyceride level.

  1998cites this paper
• A common genetic mechanism determines plasma apolipoprotein B levels and dense LDL subfraction distribution in familial combined hyperlipidemia.

  1998cites this paper
• Metabolic and genetic aspects of familial combined hyperlipidaemia with emphasis on low‐density lipoprotein heterogeneity

  1997cites this paper
• Segregation analysis of plasma apolipoprotein B levels in familial combined hyperlipidemia.

  1997cites this paper
• The redox status of coenzyme Q10 in total LDL as an indicator of in vivo oxidative modification. Studies on subjects with familial combined hyperlipidemia.

  1997cites this paper
• Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.

  1997cites this paper
• [Familial combined hyperlipidemia].

  1997cites this paper
• Nonobese patients with familial combined hyperlipidemia are insulin resistant compared with their nonaffected relatives.

  1997cites this paper
• Effects of gemfibrozil or simvastatin on apolipoprotein-B-containing lipoproteins, apolipoprotein-CIII and lipoprotein(a) in familial combined hyperlipidaemia.

  1996cites this paper
• Apolipoprotein E polymorphism influences lipid phenotypic expression, but not the low density lipoprotein subfraction distribution in familial combined hyperlipidemia.

  1996cites this paper
• Journal of Medicine Elsevier Effects of Gemfibrozil or Simvastatin on Apolipoprotein-b-containing Lipoproteins, Apolipoprotein-ciii and Lipoproteint A) in Familial Combined Hyperlipidaemia

  year unknowncites this paper